Ticker Details
Eli Lilly & Co. Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$1.09T
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.57 | 1.10%
Avg Daily Range (30 D):	$18.15 | 1.60%
Avg Daily Range (90 D):	$16.24 | 1.61%

Institutional Daily Volume
Avg Daily Volume:	4.29M
Avg Daily Volume (30 D):	2.54M
Avg Daily Volume (90 D):	2.43M

Trade Size
Avg Trade Size (Sh.):	108
Avg Trade Size (Sh.) (30 D):	20
Avg Trade Size (Sh.) (90 D):	19

Institutional Trades
Total Institutional Trades:	88,103
Avg Institutional Trade:	$10.81M
Avg Institutional Trade (30 D):	$124.73M
Avg Institutional Trade (90 D):	$102.24M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	15

Market Closing Trades
Avg Closing Trade:	$98.76M
Avg Closing Trade (30 D):	$665.69M
Avg Closing Trade (90 D):	$524.99M
Avg Closing Volume:	416.9K

News

Jul 9, 2026 @ 12:15 PM Vanguard Health Care vs. VanEck Pharmaceutical: Ho... Source: Erin Kennedy

Jul 8, 2026 @ 10:04 PM Invesco Pharmaceuticals ETF or First Trust Biotech... Source: Brendan Coffey

Jul 8, 2026 @ 6:10 PM Is It Too Late to Buy Eli Lilly? Source: Adria Cimino

Jul 8, 2026 @ 12:30 PM Prediction: Eli Lilly Stock Will Hit This Price by... Source: Micah Zimmerman

Jul 8, 2026 @ 11:28 AM BBH vs. XPH: Which Healthcare ETF Is Better for Be... Source: Sarah Sidlow

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$23	$7.4	$23
Diluted EPS	$22.95	$7.39	$22.95
Revenue	$65.18B	$19.29B	$65.18B
Gross Profit	$54.13B	$15.92B	$54.13B
Net Income / Loss	$20.64B	$6.64B	$20.64B
Operating Income / Loss	$25.73B	$8.27B	$25.73B
Cost of Revenue	$11.05B	$3.37B	$11.05B
Net Cash Flow	$4B	$-2523.5M	$4B
PE Ratio